|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT02993744 |
|
Date of registration:
|
07/12/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone
|
|
Scientific title:
|
Assessment of Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone Under Threat of Preterm Delivery |
|
Date of first enrolment:
|
September 2016 |
|
Target sample size:
|
140 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02993744 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Austria
| | | | | | | |
|
Contacts
|
|
Name:
|
Florian Frommlet, DI. Dr. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Medical University Vienna |
|
|
Name:
|
Maria Kastanek |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Medical University Vienna |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- week of gestation 23+0 until 34+6
Exclusion Criteria:
- infectious diseases f.e. hepatitis B or C, HIV
- diseases of the thyroid gland
75 Patients facing preterm labour 65 Patients acting as a control group, without
preterm labor
Age minimum:
18 Years
Age maximum:
50 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Preterm Birth
|
|
Primary Outcome(s)
|
|
CRP
[Time Frame: 48h]
|
|
Secondary Outcome(s)
|
|
Leucocytes
[Time Frame: 48h]
|
|
Secondary ID(s)
|
|
2130/2015
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|